ASPIRA WOMEN'S HEALTH INCASPIRA WOMEN'S HEALTH INCASPIRA WOMEN'S HEALTH INC

ASPIRA WOMEN'S HEALTH INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.31EUR
Revenue estimate
‪2.38 M‬EUR
Market capitalization
‪38.28 M‬EUR
−1.62EUR
‪−15.12 M‬EUR
‪8.29 M‬EUR
‪6.73 M‬
Beta (1Y)
1.27

About Aspira Women's Health Inc.

CEO
Nicole Sandford
Headquarters
Austin
Employees (FY)
64
Founded
1993
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CUL is 3.10 EUR — it has increased by 1.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ASPIRA WOMEN'S HEALTH INC stocks are traded under the ticker CUL.
ASPIRA WOMEN'S HEALTH INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CUL stock is 1.96% volatile and has beta coefficient of 1.27. Check out the list of the most volatile stocks — is ASPIRA WOMEN'S HEALTH INC there?
CUL earnings for the last quarter are −0.45 EUR per share, whereas the estimation was −0.48 EUR resulting in a 5.36% surprise. The estimated earnings for the next quarter are −0.40 EUR per share. See more details about ASPIRA WOMEN'S HEALTH INC earnings.
ASPIRA WOMEN'S HEALTH INC revenue for the last quarter amounts to ‪2.10 M‬ EUR despite the estimated figure of ‪2.75 M‬ EUR. In the next quarter revenue is expected to reach ‪2.29 M‬ EUR.
Yes, you can track ASPIRA WOMEN'S HEALTH INC financials in yearly and quarterly reports right on TradingView.
CUL stock has fallen by 6.06% compared to the previous week, the month change is a 3.13% fall, over the last year ASPIRA WOMEN'S HEALTH INC has showed a 31.11% decrease.
CUL net income for the last quarter is ‪−2.80 M‬ EUR, while the quarter before that showed ‪−4.45 M‬ EUR of net income which accounts for 37.13% change. Track more ASPIRA WOMEN'S HEALTH INC financial stats to get the full picture.
Today ASPIRA WOMEN'S HEALTH INC has the market capitalization of ‪38.28 M‬, it has increased by 1.13% over the last week.
No, CUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASPIRA WOMEN'S HEALTH INC stock right from TradingView charts — choose your broker and connect to your account.
CUL reached its all-time high on Feb 11, 2021 with the price of 117.75 EUR, and its all-time low was 2.14 EUR and was reached on Jul 27, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 64.00 employees. See our rating of the largest employees — is ASPIRA WOMEN'S HEALTH INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASPIRA WOMEN'S HEALTH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASPIRA WOMEN'S HEALTH INC stock shows the sell signal. See more of ASPIRA WOMEN'S HEALTH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASPIRA WOMEN'S HEALTH INC future price: according to them, CUL price has a max estimate of 6.67 EUR and a min estimate of 3.06 EUR. Read a more detailed ASPIRA WOMEN'S HEALTH INC forecast: see what analysts think of ASPIRA WOMEN'S HEALTH INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASPIRA WOMEN'S HEALTH INC EBITDA is ‪−16.43 M‬ EUR, and current EBITDA margin is −203.77%. See more stats in ASPIRA WOMEN'S HEALTH INC financial statements.